Michael S. Weiss

2020 - TG Therapeutics

In 2020, Michael S. Weiss earned a total compensation of $32.5M as Chief Executive Officer and President at TG Therapeutics, a 156% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$233,153
Salary$1,392,470
Stock Awards$30,871,615
Total$32,497,238

Weiss received $30.9M in stock awards, accounting for 95% of the total pay in 2020.

Weiss also received $233.2K in non-equity incentive plan and $1.4M in salary.

Rankings

In 2020, Michael S. Weiss' compensation ranked 93rd out of 13,090 executives tracked by ExecPay. In other words, Weiss earned more than 99.3% of executives.

ClassificationRankingPercentile
All
93
out of 13,090
99th
Division
Manufacturing
21
out of 5,618
100th
Major group
Chemicals And Allied Products
5
out of 2,251
100th
Industry group
Drugs
5
out of 1,951
100th
Industry
Pharmaceutical Preparations
3
out of 1,456
100th
Source: SEC filing on April 29, 2022.

Weiss' colleagues

We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2020.

2020

Sean Power

TG Therapeutics

Chief Financial Officer

News

You may also like